News

Last week, Heart Valve Voice once again teamed up with our partners at Valve for Life UK for another Your Heart Matters event. This time, the team went to Bristol, where we were joined by clinicians from University Hospital Bristol and Weston

Yesterday Heart Valve Voice were delighted to be at Birmingham Central Library to promote awareness of heart valve disease and how it's treated.

Earlier this week, I was asked to represent Heart Valve Voice and its patient community at a Westminster Health Forum event on Next Steps for Diagnostics and Medical Devices in England. The event featured stakeholders from across the health space, with policymakers, industry professionals and clinical leaders coming together to share their thoughts and ideas. I was there as a patient to share my experience and talk more broadly about what I have learned from other patients as an advocate for Heart Valve Voice.

Essex heart patients are the first in the country to benefit from new wearable technology used by hospital staff in a revolutionary procedure.

In 2019, at just 33 years old, Stacey Langridge was experiencing severe shortness of breath and swollen ankles. When referred to Weston General Hospital, it was found that she had aortic stenosis, mitral valve disease and endocarditis and needed emergency treatment. Over the next four weeks in the hospital, she had her valves repaired and replaced and antibiotics to treat her endocarditis. Now, she is making a good recovery, adjusting to life after treatment, and looking forward to the future with her family.

This week, NHS England (NHSE) issued a statement updating guidance on using TAVI to treat severe symptomatic aortic stenosis (AS). In the statement, NHSE confirms that TAVI is an alternative to surgical intervention for patients with severe symptomatic aortic stenosis who are at high surgical risk, and has extended its suitability for those at intermediate or low surgical risk, who meet the detailed inclusion criteria which accompanies the document.